About Me

Dr Saboora Waris joined Maroof International Hospital in December 2022 as Associate Director of Research. She is managing and coordinating the multiple international ongoing clinical trials (REVISE, ALVOEYE, HIPPATTACK and PEADS MALNUTRITION). She is also responsible for making more collaborations with more international and domestic stakeholders for MIH Research Department. She is also running a program on capacity building in the field of clinical research at Maroof International Hospital.

Prior to this, she worked as a Clinical trial site in charge and Co-investigator of an international Project with Chinese Sponsors Anhui Zhifei Longcom biopharmaceutical co. ltd: “A Phase III Randomized, Double-blind, Placebo-controlled Clinical Trial in 18 Years of Age and Above to Determine the Safety and Efficacy of ZF2001, a Recombinant Novel Coronavirus Vaccine (CHO cell) for Prevention of COVID-19” at Shaheed Zulfiqar Ali Bhutto Medical University Clinical Trial Unit. The success of this trial is already published in the New England Journal of Medicine (Impact factor 2021: 176). In 2019, she joined Shaheed Zulfiqar Ali Bhutto Medical University Islamabad as Assistant Professor (IPFP). She won a research grant as a principal investigator in unravelling the genetic molecular landscape of high-grade gliomas in Pakistani patients

Dr Saboora Waris graduated from Monash University, Australia in 2017 with a PhD in Biochemistry/Molecular Biology. During her PhD, she characterized RNA binding proteins TIA-1, TIAR and HuR involved in stress granule formation. Her research interests in general, include understanding the role of RNA/DNA binding proteins in various cancers and infectious diseases, molecular pathogenesis of glioblastomas, and neurodegenerative diseases. Her work was published in high-impact international journals; the International journal of molecular sciences, Nucleic acids research, Cell Reports Advanced Drug Delivery Reviews and the New England Journal of Medicine. She received several awards and honours which included the Monash graduate scholarship (MGS), Monash international postgraduate research scholarship (MIPRS) and Young Investigator Travel Award given by the American Protein Society in 2016 and 2018.